NIH con­tributes bil­lions to new drug de­vel­op­ment. GAO says patents don't tell the full sto­ry

The Na­tion­al In­sti­tutes of Health, which con­tin­ues to wait for Pres­i­dent Biden’s nom­i­na­tion of its next leader, spends hun­dreds of bil­lions on re­search that trans­lates in­to bio­med­ical break­throughs and new drug ap­provals. But the ex­act ex­tent to which NIH con­tributes to drug de­vel­op­ment is still “dif­fi­cult to mea­sure and not well un­der­stood,” a new Gov­ern­ment Ac­count­abil­i­ty Of­fice re­port re­leased Thurs­day found.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER